ICM
RVPHW

Ionic Capital Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Ionic Capital Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-135,481
Closed -$69K – 376
2021
Q2 		$69K Buy
+135,481
New +$61K 0.01% 354

Other funds holding RVPHW

BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Ionic Capital Management's RVPHW Position: Q3 2021 in Review

Ionic Capital Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2021, closing a stake of 135,481 shares — an estimated $69K sold.

Ionic Capital Management first reported a position in RVPHW in Q2 2021 and held it in 1 quarter. The position peaked at $69K in Q2 2021. 8 funds tracked by Wall St. Rank hold RVPHW as of Q3 2021.

  • Ionic Capital Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2021 after selling out during the quarter.
  • Ionic Capital Management sold 135,481 Reviva Pharmaceuticals Warrants shares in Q3 2021, an estimated $69K.
  • Ionic Capital Management first reported a position in Reviva Pharmaceuticals Warrants in Q2 2021 and held it in 1 quarter.
  • Ionic Capital Management's Reviva Pharmaceuticals Warrants position peaked at $69K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2021.

Based on Ionic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.